US EditionPublished • loading... • Updated
Drug pricing, medicine access concerns at DRAP
Summary by Minute Mirror
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Drug pricing, medicine access concerns at DRAP
Islamabad: In a recent live “E-Kachehri” session hosted by the Drug Regulatory Authority of Pakistan (DRAP), public concerns about drug pricing and the availability of essential medicines took center stage. The session, led by CEO Dr. Obaidullah, allowed stakeholders to raise issues directly with the regulatory body, shedding light on significant challenges within the pharmaceutical sector. One of the major issues discussed was the disparity in …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
